Maria Laura Bisegna | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation	EUROPEAN JOURNAL OF HAEMATOLOGY	2024
Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report	FRONTIERS IN ONCOLOGY	2024
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia	JOURNAL OF CLINICAL MEDICINE	2024
Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New Compounds	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA	2023
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients	EXPERT REVIEW OF HEMATOLOGY	2022
Trapianto di cellule staminali	Ematologia Smart, Edizioni Idelson Gnocchi 1908	2022
Diagnostica di laboratorio e strumentale	Ematologia Smart, Edizioni Idelson Gnocchi 1908	2022
Reduced Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) colonization in a hematological-emergency setting during the coronavirus disease 2019 (COVID-19) pandemic	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY	2022
CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New Directions	CURRENT HEMATOLOGIC MALIGNANCY REPORTS	2022
RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohort	BLOOD ADVANCES	2022
Utility of Flow Cytometry Ascitic Fluid Analysis for Rapid Diagnosis of B-Cell Peritoneal Lymphomatosis	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2022